Biotech Values

[oc631]

Yes, it's in Phase 1 now with data due in mid-2013 I believe. I'm sure they will need these results, at a minimum, before they have a chance to partner.

It's somewhat surprising the stock doubled on that animal data because it's meaningless without demonstrating stellar safety in humans first. It's a long shot but you have a pretty strong batting average. Let me know when or if you buy in.